Target intelligence / Profile preview

Non-Neuropilin-2 messenger RNAs with seed-region complementarity

Molecular classification
Messenger RNA (mRNA)
01

Overview

Non-NRP2 mRNAs with seed-region complementarity refers to a population of messenger RNA (mRNA) transcripts that are unintentionally targeted by RNA interference (RNAi) molecules, such as siRNAs or miRNAs, designed to inhibit Neuropilin-2 (NRP2) [1]. This interaction is driven by the seed region of the small RNA—typically nucleotides 2 through 8—which can bind to complementary sequences in the 3' untranslated regions (UTRs) of various non-target mRNAs [2]. When this binding occurs, the RNA-induced silencing complex (RISC) may degrade these unintended transcripts or repress their translation, leading to off-target effects that can confound experimental results or cause clinical toxicity [3]. While NRP2 is a legitimate therapeutic target due to its role in promoting tumor angiogenesis, lymphangiogenesis, and metastasis, these complementary non-target mRNAs represent a significant hurdle in the development of highly specific RNAi-based drugs [1]. Monitoring these off-target interactions is essential during the preclinical development of NRP2-targeting agents to ensure that the observed phenotypic changes are due to NRP2 knockdown rather than the silencing of other essential genes [2]. Consequently, this term describes a safety-related phenomenon in pharmacology rather than a specific biological receptor or enzyme [3].

Other names
Off-target transcriptsSeed-matched off-targetsNon-specific RNAi targetsNRP2 siRNA off-targets
02

Mechanism of action

RNA interference (RNAi) mediated by the RISC complex, where the seed region of a guide RNA binds to complementary sequences in the 3' UTR of non-target mRNAs, leading to their degradation or translational inhibition [1][3].

03

Biological functions

Protein translationRegulation of gene expression
04

Disease associations

Drug-induced toxicityUnintended pathway modulation
05

Safety considerations

Off-target gene silencingUnintended phenotypic changesPotential for systemic toxicitySaturation of the RNAi machinery
06

Interacting drugs

Experimental NRP2-targeting siRNAs

1 more in the full profile.

07

Biomarkers

Global gene expression profiles (RNA-seq)Reporter gene assays for seed-region specificityProtein expression levels of predicted off-target genes

Beyond the preview

Go deeper on Non-Neuropilin-2 messenger RNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-Neuropilin-2 messenger RNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call